Provided by Tiger Trade Technology Pte. Ltd.

Olema Pharmaceuticals, Inc.

7.94
+0.02000.25%
Post-market: 7.940.00000.00%16:15 EDT
Volume:818.55K
Turnover:6.60M
Market Cap:692.03M
PE:-3.73
High:8.23
Open:7.90
Low:7.79
Close:7.92
52wk High:36.26
52wk Low:6.65
Shares:87.16M
Float Shares:71.89M
Volume Ratio:0.72
T/O Rate:1.14%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1289
EPS(LYR):-1.8700
ROE:-52.74%
ROA:-31.82%
PB:1.61
PE(LYR):-4.25

Loading ...

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Oct 03

Olema Reaffirmed at Buy as Palazestrant Data and SERD Market Momentum Support Unchanged $36 Price Target

TIPRANKS
·
Sep 21

Olema Pharmaceuticals (OLMA) Receives a Rating Update from a Top Analyst

TIPRANKS
·
Sep 21

Olema Pharmaceuticals is Maintained at Buy by Stifel

Dow Jones
·
Sep 15

Top Premarket Decliners

MT Newswires Live
·
Sep 14

Goldman Sachs Reaffirms Their Buy Rating on Olema Pharmaceuticals (OLMA)

TIPRANKS
·
Sep 14

Olema selloff on AstraZeneca miss a buying opportunity, says Citi

TIPRANKS
·
Sep 14

Olema Maintained at Buy as Analyst Sees Post-SERENA-4 Pullback as Opportunity, Reiterates $59 Price Target

TIPRANKS
·
Sep 14

Analysts Offer Insights on Healthcare Companies: Smith & Nephew Snats (SNN) and Olema Pharmaceuticals (OLMA)

TIPRANKS
·
Aug 20

Olema Oncology appoints Jason O’Byrne as CFO

TIPRANKS
·
Aug 17

Olema Pharmaceuticals is Maintained at Overweight by JP Morgan

Dow Jones
·
Aug 13

Olema Pharmaceuticals Names Jason O’Byrne CFO

Reuters
·
Aug 13

Olema Oncology Appoints Jason O’byrne as Chief Financial Officer

THOMSON REUTERS
·
Aug 13

Press Release: Olema Oncology Appoints Jason O'Byrne as Chief Financial Officer

Dow Jones
·
Aug 13

Longeveron Q2 Net Loss Widens on Higher Legal, Clinical Trial Costs

Reuters
·
Aug 13

Sutro Biopharma Q2 Revenue Misses Estimates, Posts Wider Loss

Reuters
·
Aug 12

Oncology Firm Immunome's Q2 Net Loss Widens as R&D Costs Rise

Reuters
·
Aug 12

Sellas Life Sciences Q2 Net Loss Widens on Higher Expenses

Reuters
·
Aug 12

Erasca Q2 Net Loss Widens on Higher R&D Costs

Reuters
·
Aug 12

Olema Pharmaceuticals Stock Falls as Pivotal Breast Cancer Data Pushed Into 2027

Benzinga Earnings
·
Aug 12